View in EDS HTML Full Text PDF Full Text

Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025.

Saved in:
Bibliographic Details
Title: Antiviral Activity of Remdesivir and Obeldesivir Against SARS-CoV-2 Omicron Subvariants That Were Circulating from September 2023 Through June 2025.
Authors: Rodriguez, Lauren1 (AUTHOR) lauren.rodriguez14@gilead.com, Li, Jiani1 (AUTHOR), Han, Dong1 (AUTHOR), Peinovich, Nadine1 (AUTHOR), Martinez, Clarissa1 (AUTHOR), Ho, Pui Yan1 (AUTHOR), Zamora, J. Lizbeth Reyes1 (AUTHOR), Martin, Ross1 (AUTHOR), Bilello, John P.1 (AUTHOR), Perry, Jason K.1 (AUTHOR), Hedskog, Charlotte1 (AUTHOR)
Source: Viruses (1999-4915). Feb2026, Vol. 18 Issue 2, p255. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19994915
DOI:10.3390/v18020255